Manufacturing

Recipharm expects to be rolling out further serialization projects during 2015.

The investments made in analytical and process development equipment will enable Laurus Synthesis to offer chemistry services to its clients.

UPS expands its special commodities program to more countries.

Real-time, noncontact imaging and spectroscopy techniques provide insight into pharmaceutical processes.

A new machine is designed for inspection of prefilled syringes.

Several chromatographic resins are available for downstream purification.

Member of parliament, Desmond Swayne, will officially open the 42,000-square-foot facility on March 20, 2015.

The new flow sensors, BioPAT Flow, enable precise, reproducible data to be collected on flow rates and mass balances without coming in contact with the medium during measurement.

The manufacture and scale up production mark a significant milestone in the commercialization route of Nanobiotix lead product, NBTXR3.

WuXi's new facility in Philadelphia will manufacture CAR T-cell therapies and other cancer immunotherapies.

NSF's consensus-based standard incorporates multiple regulatory and industry requirements into a single rigorous standard for the manufacturing and distribution of pharmaceutical excipients.

Penn Pharma's equipment addition meets growing need for continuous dry granulation and for handling of highly potent drugs.

Innovative equipment, analytical techniques, software, and modeling systems are improving the tableting process.

Analytical technologies must accurately identify and measure the critical material attributes of APIs and excipients.

PAT has aided formulation, both pre-and post-filing, by reducing costs and time frames.

Ionic liquid technologies offer a new way to improve bioavailability.

New technologies for solid dosage manufacturing are examined.

New cellulosic polymers have been shown to improve solubility in these key amorphous solid dispersion processes.

McNeil-PPC pleads guilty in connection with adulterated infants' and children's over-the-counter liquid medications.

BIO and the Colorado BioScience Association urge Colorado Governor Hickenlooper to sign a bill that will help patients gain access to interchangeable biologic products following FDA approvals.

In a landmark decision, FDA approved Zarxio, making it the first biosimilar product in the United States.

BASF is expanding its Verbund site in Ludwigshafen to include production capacity for about 20 specialty amines.

Teva announced that it would sell its Sellersville, Pennsylvania facility to G&W Laboratories.

WellSpring Pharma Services has announced the appointment of David Mayers as president.

A facility expansion adds space for production of Repligen’s tangential flow system.